i.v. PCA EA
biochemical recurrence (PSA >0.1ng/ml)
yes
no

45 (42.9%)
60 (57.1%)

79 (42.5%)
107 (57.5%)
metastases
yes
no

5 (4.7%)
101 (95.3%)

14 (7.7%)
169 (92.3%)
death
yes
no

14 (13.6%)
89 (86.4%)

30 (16.6%)
151 (83.4%)
Table 3: Clinical outcome.